Concepedia

Greg Hollingworth

GH

2

Publications

112

Citations

2

H-Index

2014

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Novartis Institutes for BioMedical Research

Greg Hollingworth is an author at Novartis (Switzerland) specializing in drug discovery, pulmonary vascular disease, and cardiovascular pharmacology.

Top concepts

Publications per year

2014–2024

2

Publications

2

DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance

Martin Schröder, Martin Renatus, Xiaoyou Liang et al. · Nature Communications · 2024 · 71 citations · Full text

Novel ROCK inhibitors for the treatment of pulmonary arterial hypertension

Duncan Shaw, Greg Hollingworth, Nicolas Soldermann et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 41 citations · Full text

, , +10

Rows per page

1–2 of 2